C
62.99
2.00 (3.28%)
| Previous Close | 60.99 |
| Volume | 3,573,311 |
| Price / Earnings (Forward) | 11.22 |
| Price / Sales | 0.150 |
| Price / Book | 1.36 |
| 52 Weeks Range |
| Profit Margin | 2.25% |
| Operating Margin (TTM) | 4.49% |
| Diluted EPS (TTM) | 6.78 |
| Quarterly Revenue Growth (YOY) | 16.60% |
| Quarterly Earnings Growth (YOY) | 12.70% |
| Total Debt/Equity (MRQ) | 65.38% |
| Current Ratio (MRQ) | 1.11 |
| Operating Cash Flow (TTM) | 2.12 B |
| Levered Free Cash Flow (TTM) | 2.51 B |
| Return on Assets (TTM) | 3.86% |
| Return on Equity (TTM) | 12.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Mixed | Bullish |
| Healthcare Plans (Global) | Mixed | Bullish | |
| Stock | Centene Corporation | Mixed | Bullish |
AIStockmoo Score
0.3
| Analyst Consensus | NA |
| Insider Activity | 1.5 |
| Price Volatility | -3.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -0.5 |
| Average | 0.25 |
|
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Mid Core |
| % Held by Insiders | 0.46% |
| % Held by Institutions | 99.81% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| COUGHLIN CHRISTOPHER J | 62.12 | - | 583 | 36,216 |
| EPPINGER FREDERICK H | 62.12 | - | 864 | 53,672 |
| SAMUELS THEODORE R. II | 62.12 | - | 583 | 36,216 |
| TANJI KENNETH | 62.12 | - | 603 | 37,458 |
| TYLER LAUREN M | 62.12 | - | 482 | 29,942 |
| Aggregate Net Quantity | 3,115 | |||
| Aggregate Net Value ($) | 193,504 | |||
| Aggregate Avg. Buy ($) | 62.12 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| EPPINGER FREDERICK H | Director | 30 Sep 2026 | Acquired (+) | 864 | 62.12 | 53,672 |
| COUGHLIN CHRISTOPHER J | Director | 30 Sep 2026 | Acquired (+) | 583 | 62.12 | 36,216 |
| SAMUELS THEODORE R. II | Director | 30 Sep 2026 | Acquired (+) | 583 | 62.12 | 36,216 |
| TANJI KENNETH | Director | 30 Sep 2026 | Acquired (+) | 603 | 62.12 | 37,458 |
| TYLER LAUREN M | Director | 30 Sep 2026 | Acquired (+) | 482 | 62.12 | 29,942 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |